The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast. This could be due to increase in geriatric population encountering GERD (Gastroesophageal reflux disease), poor eating habits causing acidity, and the ill-effects of anti-inflammatory, non-steroidal drugs.
It’s a known fact that amongst the elderly populace, there is a recurrence of acidic complications. This comes across as a challenge for gastroenterologist as well as the primary care provider. Plus, these patients do suffer from disorders like erosive esophagitis, esophageal cancer, and Barrett esophagus. The treatment herein needs an amalgamation of therapies. This is where antacids come into picture.
Full Research Report On Global Antacids Market Analysis available at: https://www.millioninsights.com/industry-reports/antacids-market
Besides, growth in e-Commerce is expected to drive demand for antacids via online retailing channels in the subsequent years. In other words, growing popularity on the part of e-Commerce coupled with increase in online medicine providers is expected to bolster the market. At the same time, restraints do exist in the form of intake by young children. “Gut” journal states that young children displayed obesity symptoms on intake of antacids. As far as infants are concerned, antacids are a strict “no-no”. Even during pregnancy antacids should be avoided as chances of pre-mature birth can’t be ruled out.
The antacids market is segmented on the basis of drug class, type of formulation, distribution channel, and geography. By drug class, the segmentation spans proton pump inhibitors, H2 antagonist (interventional/surgical simulators), and acid neutralizers. By type of formulation, the antacids industry comprises tablet, liquid, and powder. By distribution channel, it consists of retail pharmacies, hospital pharmacies, and the other distribution channels. By geography, the antacid market is segmented into North America, LATAM, Asia Pacific, Europe, and MEA.
The players contributing to the antacids market include Bayer AG, AstraZeneca PLC, Sanofi S.A., Reckitt Benckiser Group PLC, Procter & Gamble, Pfizer Inc., Johnson & Johnson, and Dr. Reddy’s Laboratories Ltd.
Request for Free Sample Copy at: https://www.millioninsights.com/industry-reports/antacids-market/request-sample
Market Segment:
Antacid Dosage Form Outlook (Revenue, USD Million, 2014 - 2025)
• Tablet
• Liquid
• Others
Antacid Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Antacid Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa
Related Reports of this Category available at Million Insights: https://www.millioninsights.com/industry/pharmaceuticals
About Million Insights
Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.
For More Information: www.millioninsights.com
Media Contact
Company Name: Million Insights
Contact Person: Ryan Manuel
Email:Send Email
Phone: 91-20-65300184
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City: Pune
State: Maharashtra
Country: India
Website: https://www.millioninsights.com/industry-reports/antacids-market
